Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-02

Clinical Trial Update: Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updates beta-arrestins’ relationship with venlafaxine response in adults with major depressive disorder. The study (DEPARRESTCLIN) has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Major Depressive Disorder, Major Depressive Episode | Phase 4 | Status: COMPLETED